BODALCHEM.NS BODALCHEM NSE
₹70.90
-9.00% 1Y
Market & Price
Market Cap
-
Current Price
₹70.90
High / Low (52W)
₹78.99 / ₹43.45
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
8.35%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹2.55
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹2,355.77 Cr
Current Assets
₹934.39 Cr
Working Capital
₹172.84 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
9.22%
Profit 5Y
7.94%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | 443.47 Cr | 450.87 Cr | 454.20 Cr | 480.45 Cr | 489.57 Cr | 588.02 Cr |
| Cost of Revenue | - | 215.55 Cr | 217.29 Cr | 237.53 Cr | 274.12 Cr | 275.52 Cr | 322.92 Cr |
| Gross Profit | - | 227.92 Cr | 233.59 Cr | 216.67 Cr | 206.33 Cr | 214.04 Cr | 265.09 Cr |
| Operating Expenses | - | 199.04 Cr | 201.00 Cr | 185.12 Cr | 198.87 Cr | 208.45 Cr | 211.13 Cr |
| Operating Income | - | 28.88 Cr | 32.59 Cr | 31.55 Cr | 7.46 Cr | 5.59 Cr | 53.96 Cr |
| EBITDA | - | 45.15 Cr | 49.60 Cr | 51.66 Cr | 42.88 Cr | 37.13 Cr | 71.15 Cr |
| Interest Expense | - | 19.71 Cr | 21.00 Cr | 21.63 Cr | 19.91 Cr | 19.44 Cr | 17.83 Cr |
| Pretax Income | - | 8.18 Cr | 11.60 Cr | 12.52 Cr | 5.55 Cr | 23.50 L | 36.07 Cr |
| Tax Provision | - | 2.76 Cr | -2.91 Cr | 2.99 Cr | -44.10 L | -70,000 | 4.01 Cr |
| Net Income | - | 5.42 Cr | 14.50 Cr | 9.53 Cr | 5.99 Cr | 24.20 L | 32.06 Cr |
| Diluted EPS | -0.02 | 0.43 | 1.15 | 0.76 | 0.47 | 0.02 | 2.55 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,544.47 Cr | 1,362.94 Cr | 1,748.43 Cr | 2,012.24 Cr |
| Cost of Revenue | - | 1,144.85 Cr | 994.76 Cr | 885.93 Cr | 1,110.10 Cr |
| Gross Profit | - | 399.63 Cr | 368.18 Cr | 862.50 Cr | 902.14 Cr |
| Operating Expenses | - | 313.90 Cr | 317.77 Cr | 760.38 Cr | 803.58 Cr |
| Operating Income | - | 85.72 Cr | 50.41 Cr | 102.12 Cr | 98.56 Cr |
| EBITDA | - | 143.14 Cr | 117.24 Cr | 169.40 Cr | 202.82 Cr |
| Interest Expense | - | 39.21 Cr | 52.02 Cr | 81.58 Cr | 78.82 Cr |
| Pretax Income | - | 50.84 Cr | 4.73 Cr | 19.31 Cr | 54.38 Cr |
| Tax Provision | - | 12.80 Cr | -1.74 Cr | 80.70 L | 6.55 Cr |
| Net Income | - | 38.03 Cr | 6.47 Cr | 18.50 Cr | 47.83 Cr |
| Diluted EPS | - | 3.03 | 0.51 | 1.47 | 3.80 |
Compounded Sales Growth
| 5 Years: | 9.22% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | 7.94% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -9.00% |
| 6 Months: | +29.76% |
| 3 Months: | +47.19% |
| 1 Month: | +2.95% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 2,120.90 Cr | 2,287.88 Cr | 2,352.90 Cr | 2,355.77 Cr |
| Current Assets | - | 850.88 Cr | 813.49 Cr | 897.96 Cr | 934.39 Cr |
| Cash & Equivalents | - | 16.80 Cr | 23.91 Cr | 23.44 Cr | 16.77 Cr |
| Inventory | - | 292.53 Cr | 267.25 Cr | 337.24 Cr | 323.59 Cr |
| Receivables | - | 420.28 Cr | 380.81 Cr | 398.91 Cr | 438.63 Cr |
| Total Liabilities | - | 1,043.20 Cr | 1,205.64 Cr | 1,248.06 Cr | 1,198.23 Cr |
| Current Liabilities | - | 621.35 Cr | 694.38 Cr | 766.91 Cr | 761.55 Cr |
| Long Term Debt | - | 361.83 Cr | 443.00 Cr | 406.48 Cr | 340.17 Cr |
| Total Debt | - | 698.05 Cr | 903.80 Cr | 910.91 Cr | 813.19 Cr |
| Total Equity | - | 1,077.70 Cr | 1,082.24 Cr | 1,104.85 Cr | 1,157.54 Cr |
| Shares Outstanding | - | 12.56 Cr | 12.58 Cr | 12.59 Cr | 12.59 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 289.90 Cr | 204.25 Cr | 113.78 Cr | 175.97 Cr |
| Investing Cash Flow | - | -310.06 Cr | -261.63 Cr | -37.01 Cr | 10.65 Cr |
| Financing Cash Flow | - | 32.66 Cr | 80.98 Cr | -73.46 Cr | -191.46 Cr |
| Capital Expenditure | - | -337.76 Cr | -244.97 Cr | -46.45 Cr | -35.77 Cr |
| Free Cash Flow | - | -47.86 Cr | -40.72 Cr | 67.33 Cr | 140.21 Cr |
| Net Change in Cash | - | 12.49 Cr | 23.59 Cr | 3.32 Cr | -4.83 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 25.9% | 27.0% | 49.3% | 44.8% |
| Operating Margin % | - | 5.6% | 3.7% | 5.8% | 4.9% |
| Net Margin % | - | 2.5% | 0.5% | 1.1% | 2.4% |
| ROE % | - | 3.5% | 0.6% | 1.7% | 4.1% |
| ROCE % | - | 5.7% | 3.2% | 6.4% | 6.2% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BODALCHEM
No recent headlines available.